Your browser doesn't support javascript.
loading
MSH3 modifies somatic instability and disease severity in Huntington's and myotonic dystrophy type 1.
Flower, Michael; Lomeikaite, Vilija; Ciosi, Marc; Cumming, Sarah; Morales, Fernando; Lo, Kitty; Hensman Moss, Davina; Jones, Lesley; Holmans, Peter; Monckton, Darren G; Tabrizi, Sarah J.
Afiliación
  • Flower M; Department of Neurodegenerative Disease and Dementia Research Institute, UCL, UK.
  • Lomeikaite V; Institute of Molecular, Cell and Systems Biology, University of Glasgow, UK.
  • Ciosi M; Institute of Molecular, Cell and Systems Biology, University of Glasgow, UK.
  • Cumming S; Institute of Molecular, Cell and Systems Biology, University of Glasgow, UK.
  • Morales F; Institute of Molecular, Cell and Systems Biology, University of Glasgow, UK.
  • Lo K; Instituto de Investigaciones en Salud (INISA), Universidad de Costa Rica, San José, Costa Rica.
  • Hensman Moss D; School of Mathematics and Statistics, University of Sydney, Australia.
  • Jones L; Department of Neurodegenerative Disease and Dementia Research Institute, UCL, UK.
  • Holmans P; MRC Centre for Neuropsychiatric Genetics and Genomics, Cardiff University, UK.
  • Tabrizi SJ; Institute of Molecular, Cell and Systems Biology, University of Glasgow, UK.
Brain ; 2019 Jun 19.
Article en En | MEDLINE | ID: mdl-31216018
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Idioma: En Revista: Brain Año: 2019 Tipo del documento: Article País de afiliación: Reino Unido
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Idioma: En Revista: Brain Año: 2019 Tipo del documento: Article País de afiliación: Reino Unido